/Companies

Talaris Therapeutics

Louisville, US · Delaware corporation · 10 known investors

Find your way into Talaris Therapeutics

Sign up to see every warm intro you have to Talaris Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Talaris Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions

Founders & leadership

SI
Suzanne IldstadFounder
SRScott Requadt
Scott RequadtExecutive
GM
Geoff MackayNamed on SEC filing
FN
Francois NaderNamed on SEC filing

Board

SASandip Agarwala
Sandip AgarwalaBoard Member2018–2023Managing Director at Blue Owl Capital
MMMark McDade
Mark McDadeBoard directorGeneral Partner at Qiming Healthcare
NG
Nick GalakatosBoard director

Investors · 10

Funding

SEC filings, press & company announcements

$115M disclosed across 1 of 2 rounds · 2019–2020

▶$115MraisedOct 2020 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sandip AgarwalaDirector
  • Scott RequadtExecutive Officer, Director
  • Geoff MackayDirector
  • Francois NaderDirector
  • Mark McDadeDirector
  • Nick GalakatosDirector
  • Suzanne IldstadExecutive Officer, Director
Offering amount
$115M
Amount sold
$115M
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Talaris Therapeutics do?
Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions
Who founded Talaris Therapeutics?
Talaris Therapeutics was founded by Suzanne Ildstad.
Who are Talaris Therapeutics's investors?
Talaris Therapeutics's investors include Aisling Capital, Keyhorse Capital, Longitude Capital, Qiming Venture Partners USA, Viking Global, Blackstone Life Sciences, Citadel, Invus and 2 more.
How much funding has Talaris Therapeutics raised?
Talaris Therapeutics has disclosed $115M raised across 1 of its 2 known rounds.
Where is Talaris Therapeutics headquartered?
Talaris Therapeutics is headquartered in Louisville, US.